These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8677245)

  • 1. Preferred risk underwriting: what are the choices?
    Wesley D
    Med Sect Proc; 1995; ():151-9. PubMed ID: 8677245
    [No Abstract]   [Full Text] [Related]  

  • 2. Pricing implications of trends in population mortality and underwriting effectiveness.
    Pokorski RJ
    J Insur Med; 2004; 36(1):54-9. PubMed ID: 15104030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic testing legislation: a review of the past two years.
    Zimmerman SE; Meyer RB
    J Insur Med; 1998; 30(4):265-6. PubMed ID: 10537933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Life insurance: opportunities for reducing claims loss?
    Roberts NK
    J Insur Med; 1998; 30(3):135-7. PubMed ID: 10351173
    [No Abstract]   [Full Text] [Related]  

  • 5. Prognostic aspects of the metabolic syndrome.
    Regenauer A
    J Insur Med; 1998; 30(3):180-90. PubMed ID: 10351179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality experience in the elderly in the Impairment Study Capture System.
    Ashley T; Titcomb CP; Hart A; Bergstrom R
    J Insur Med; 2008; 40(2):110-5. PubMed ID: 19119589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationships between treated hypertension and subsequent mortality in an insured population.
    Ivanovic B; Cumming ME; Pinkham CA
    J Insur Med; 2004; 36(1):16-26. PubMed ID: 15104026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic testing in insurance underwriting: a blessing or a curse? An examination of the tension between economics and equity in using genetic testing in risk classification.
    Anderson MC
    Creighton Law Rev; 1992 Jun; 25(4):1499-535. PubMed ID: 11654461
    [No Abstract]   [Full Text] [Related]  

  • 9. The science of lipidology impacts underwriting and improves mortality.
    Gleeson R
    J Insur Med; 2009; 41(3):197-200. PubMed ID: 20377099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AIDS-related insurance claim experience.
    Case D
    J Insur Med; 1994; 26(1):10-3. PubMed ID: 10147062
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of body mass index and waist circumference as predictors of all-cause mortality in a male insured lives population.
    Cumming ME; Pinkham CA
    J Insur Med; 2008; 40(1):26-33. PubMed ID: 18924364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumors of underwriting interest.
    Iacovino JR
    Med Sect Proc; 1994; ():81-7. PubMed ID: 7659720
    [No Abstract]   [Full Text] [Related]  

  • 13. Albumin and all-cause mortality risk in insurance applicants.
    Fulks M; Stout RL; Dolan VF
    J Insur Med; 2010; 42(1):11-7. PubMed ID: 21290995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic information and life insurance risk classification and antiselection (1).
    Pokorski RJ
    J Insur Med; 1994-1995 Winter; 26(4):413-9. PubMed ID: 10150806
    [No Abstract]   [Full Text] [Related]  

  • 15. "Genetic discrimination": results of a survey of genetics professionals, primary care physicians, patients and public.
    Wertz DC
    Health Law Rev; 1998-1999; 7(3):7-8. PubMed ID: 15706715
    [No Abstract]   [Full Text] [Related]  

  • 16. Structured settlement annuities, part 1: overview and the underwriting process.
    Schmidt CJ; Singer RB
    J Insur Med; 2000; 32(3):131-6. PubMed ID: 15912913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Underwriting intracranial aneurysms.
    Pokorski R
    J Insur Med; 2009; 41(3):201-6. PubMed ID: 20377100
    [No Abstract]   [Full Text] [Related]  

  • 18. Older age underwriting: frisky vs frail.
    Bennett AK
    J Insur Med; 2004; 36(1):74-83. PubMed ID: 15104032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insurability for asymptomatic hematuria or proteinuria during childhood.
    Feld LG; Stapleton FB
    Am J Kidney Dis; 1993 Aug; 22(2):261-3. PubMed ID: 8352250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Underwriting implications of premalignant disease.
    Vecchione L
    J Insur Med; 1998; 30(3):169-74. PubMed ID: 10351177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.